SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $377,000 | -21.3% | 50,202 | -5.6% | 0.01% | -20.0% |
Q3 2021 | $479,000 | -27.8% | 53,193 | -4.1% | 0.02% | -31.8% |
Q2 2021 | $663,000 | -4.3% | 55,445 | +0.2% | 0.02% | -8.3% |
Q1 2021 | $693,000 | -24.3% | 55,321 | -5.6% | 0.02% | -22.6% |
Q4 2020 | $915,000 | -30.2% | 58,621 | -57.7% | 0.03% | -27.9% |
Q3 2020 | $1,310,000 | +0.9% | 138,682 | -4.3% | 0.04% | +22.9% |
Q2 2020 | $1,298,000 | +37.2% | 144,906 | -2.4% | 0.04% | +25.0% |
Q1 2020 | $946,000 | -23.7% | 148,502 | +0.2% | 0.03% | 0.0% |
Q4 2019 | $1,240,000 | -44.8% | 148,179 | -40.3% | 0.03% | -44.0% |
Q3 2019 | $2,245,000 | -17.0% | 248,076 | -1.2% | 0.05% | -18.0% |
Q2 2019 | $2,706,000 | +156.0% | 251,176 | +126.8% | 0.06% | +190.5% |
Q1 2019 | $1,057,000 | -22.5% | 110,726 | -6.8% | 0.02% | -27.6% |
Q4 2018 | $1,363,000 | -30.8% | 118,834 | +2.2% | 0.03% | -17.1% |
Q3 2018 | $1,971,000 | +17.4% | 116,248 | -1.7% | 0.04% | +20.7% |
Q2 2018 | $1,679,000 | -31.0% | 118,299 | -7.6% | 0.03% | -31.0% |
Q1 2018 | $2,432,000 | +16.3% | 128,021 | +0.4% | 0.04% | +16.7% |
Q4 2017 | $2,091,000 | – | 127,521 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |